SMP and AMC are each supported by a CIHR Masters Award
These findings have prompted lawsuits and other legal action against its manufacturer, Pfizer, for failing to adequately warn users about this serious risk
The injectable medication is approved for once-a-week treatment of Type 2 diabetes in adults and is sold under the brand name "Obeda" in India
He provides physician-supervised obesity treatment, including GLP-1based weight management and advanced bariatric surgery
Patients should seek immediate care for persistent severe abdominal pain that may radiate to the back (possible pancreatitis), right upper quadrant pain with fever or jaundice (possible gallbladder disease), severe abdominal distension with constipation (possible obstruction), or inability to tolerate oral intake with signs of dehydration
Rare but Serious Risks Patients with the following history are generally excluded from Retatrutide therapy: Medullary Thyroid Carcinoma (MTC): Like all GLP-1s, there is a "black box" warning regarding a family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)